S.1674 - Improving Access to Clinical Trials Act of 2009111th Congress (2009-2010)
|Sponsor:||Sen. Wyden, Ron [D-OR] (Introduced 09/15/2009)|
|Committees:||Senate - Finance|
|Latest Action:||10/05/2010 Became Public Law No: 111-255. (TXT | PDF) (All Actions)|
This bill has the status Became Law
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
Subject — Policy Area:
- Social Welfare
- View subjects
Summary: S.1674 — 111th Congress (2009-2010)All Bill Information (Except Text)
Public Law No: 111-255 (10/05/2010)
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Improving Access to Clinical Trials Act of 2009 - Amends title XVI (Supplemental Security Income) (SSI) of the Social Security Act (SSA) to exclude from income for SSI eligibility purposes any compensation in the amount of the first $2,000 per year received by an individual for participation in clinical trials involving research and testing of treatments for rare diseases or conditions.
Amends SSA title XIX (Medicaid) to make a similar exclusion from income of such compensation for the purposes of eligibility under the Medicaid program.
Directs the Comptroller General to study and report to Congress on the impact of this Act on enrollment of individuals who receive SSI benefits in clinical trials for rare diseases or conditions.